Showing 3111-3120 of 3315 results for "".
- B+L Introduces FreeFlow Infusion System and 23-Gauge Bi-Blade Dual Port Vitrectomy Cutterhttps://modernod.com/news/bausch-lomb-introduces-freeflow-infusion-system-for-retina-surgery/2476761/Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual port vitrectomy cutter for the Stellaris Elite vision enhancement system. The FreeFlow infusion system allows for higher level of infusion flow compared to previous generati
- Prism Vision Group Announces Launch of New Brandhttps://modernod.com/news/prism-vision-group-announces-launch-of-new-brand/2476726/Prism Vision Group, an ophthalmology administrative services care provider organization, was officially launched. The new entity is led by Steven Madreperla, MD, PhD, a practicing ophthalmologist and one of the founding partners of NJRetina, a specialty retina practice with roots that reac
- SIFI Announces Expansion in the French Market With Acquisition of Dacudoses and Novoptinehttps://modernod.com/news/sifi-announces-expansion-in-the-french-market-with-acquisition-of-dacudoses-and-novoptine/2479574/Italian ophthalmic company SIFI has announced the acquisition of Dacudoses and Novoptine antiseptic brands in France from Laboratoire Gifrer Barbezat. Terms of the deal were not disclosed. Dacudoses is the leading reimbursed RX brand of the French ophthalmic antiseptic segment, pres
- Alan R. Morse, JD, PhD, Vision and Healthcare Services Innovator, Will Retire As President & CEO of Lighthouse Guildhttps://modernod.com/news/alan-r-morse-jd-phd-vision-and-healthcare-services-innovator-will-retire-as-president-ceo-of-lighthouse-guild/2476695/James M. Dubin, Chairman of the Board of Lighthouse Guild, announced that Alan R. Morse, JD, PhD, will be stepping down later this year as President & CEO of Lighthouse Guild after an extraordinary career of almost 52 years as a leader and innovator in the field
- PlanetVA Launches Eyewear Virtual Try-On Platform That Creates a 3D Face Model From Selfiehttps://modernod.com/news/planetva-launches-eyewear-virtual-try-on-platform-that-creates-a-3d-face-model-from-selfie/2476684/PlanetVA announced the launch of its latest eyewear virtual try-on platform: vmPRO. By just taking a selfie, the app creates a 3D face model of the user in just a matter of seconds. This app leverages current augmented reality trends and the latest artificial intelligence algorithms to allow th
- CooperVision Showcases Latest Research in Series of Poster Sessions at Optometry’s Meeting 2019https://modernod.com/news/coopervision-showcases-latest-research-in-series-of-poster-sessions-at-optometrys-meeting-2019/2476676/As part of its commitment to the continuous advancement of contact lens study and support, CooperVision will share the results of new research in a series of four poster sessions at Optometry’s Meeting 2019 in St. Louis. The posters examine the performance of CooperVision clariti 1 day multifocal
- Gymnast Laurie Hernandez Partners With Alcon for New “Eye Can, Eye Will” Campaignhttps://modernod.com/news/gymnast-laurie-hernandez-partners-with-alcon-for-new-eye-can-eye-will-campaign/2476665/Alcon is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on the new “Eye Can, Eye Will” campaign, which is based on Laurie’s belief that clear, comfortable vision with DAILIES TOTAL1 contact lenses have helped her maintain the focus and enthusiasm needed to get to the top
- Pre-Pilot Clinical Trial from Ocutrx Vision Technologies Yields Exciting Results for Patients with AMDhttps://modernod.com/news/pre-patient-trial-from-ocutrx-vision-technologies-yields-exciting-results-for-patients-with-amd/2476659/Ocutrx Vision Technologies announced the results of the first pre-pilot clinical trial for the company’s Oculenz AR glasses. In the single arm crossover study of subjects with advanced macular degeneration, the Oculenz AR glasses significantly improved the ability of subjects to read small letter
- Allegro Ophthalmics Announces Positive Topline Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry AMDhttps://modernod.com/news/allegro-ophthalmics-announces-positive-topline-results-of-phase-2-study-evaluating-risuteganib-in-patients-with-intermediate-dry-amd/2476627/Allegro Ophthalmics announced positive topline results of its phase 2 study of risuteganib (Luminate) for the treatment of intermediate dry age-related macular degeneration (AMD). The clinical trial met its primary endpoint with 48 percent of patients in the risuteganib arm gaining ≥ 8 letters of
- Zeiss Ranked Best Company in Germany’s Public Value Atlashttps://modernod.com/news/zeiss-ranked-best-company-in-germanys-public-value-atlas/2476600/Zeiss is Germany’s highest-ranked company in the 2019 Public Value Atlas (Gemeinwohlatlas 2019). The announcement was made in Berlin by the authors of the study, the Center for Leadership and Values in Society at the University of St. Gallen (CLVS-HSG) in cooperation with the Dr. Arend Oetk